Successfull bleeding control with intermittent injection of factor VIII in a patient with hemophilia a during coronary artery bypass grafting surgery

Coronary surgery in patients with hemophilia is a challenging issue since it requires specific and a careful medical approach before, during and after the operation. Although several studies have shown the effectiveness of either intermittent or continuous infusion of factor VIII concentrates, there are no standardized schedules for the replacement therapy in these kinds of patients. We hereby present a case of severe hemophilia A and coronary event which was successfully managed by surgical approach supported by intermittent high dose factor VIII infusion. The patient underwent a surgical by-pass operation without any hemorrhagic and thrombotic complications..

Hemofili A Tanılı hastada koroner arter By-pass operasyonunda aralıklı faktör VIII uygulaması ile basarılı kanama kontrolü

Hemofili hastalarında koroner cerrahi, operasyon öncesi, operasyon sırası ve sonrasında özel ve dikkatli tıbbi yaklasım gerektirmektedir. Aralıklı veya sürekli faktör VIII infüzyonu uygulamalarının etkinlikleri açısından birkaç çalısma olmakla birlikte bu konuda net protokoller ortaya konabilmis değildir. Burada ağır hemofili A tanısı ve koroner hastalığı olan ve aralıklı yüksek doz faktör VIII infüzyonları ile basarılı bir operasyon geçiren bir hastayı sunmaktayız. By-pass operasyonu geçiren hastada kanama ve trombotik komplikasyon izlenmemistir..

Kaynakça

1. Friedman KD and Rodgers GM. Coagulation disorders. In: Greer JP, Foerster J, Lukens JN, Rodgers GM, Paraskevas F, Glader B (eds) Wintrobe’s Clinical Hematology, Lippincott Williams &Wilkins, Philadelphia, 2004: 1619–1667.

2. Stine KC, Becton DL: Use of factor VIII replacement during open heart surgery in a patient with haemophilia A. Haemophilia. 2006; 12(4):435-6.

3. Quick AJ: No aspirin for Haemophiliacs. NEJM 1971; 284(4):218.

4. Mielke CH & Britten AFH. Use of aspirin or acetaminophen in Haemophilia. NEJM 1970; 282 (22):1270.

5. MacKinlay N, Taper J, Renisson F, Rickard K. Cardiac surgery and catheterization in patients with haemophilia.Haemophilia. 2000;6(2):84-8.

6. Sramek A, Kriek M, Rosendaal FR. Decreased mortality of ischaemic heart disease among carriers of haemophilia.Lancet 2003;362:351-4.

7. Rosendaal FR, Varekamp I, Smit C, Bröcker-Vriends AH, van Dijck H, Vandenbroucke JP, Hermans J, Suurmeijer TP, Briët E. Mortality and causes of death in Dutch haemophiliacs, 1973-86. Br J Haematol 1989;71:71-6.

8. Meade TW, Cooper JA, Stirling Y, Howarth DJ, Ruddock V, Miller GJ. Factor VIII, ABO blood group and the incidence of ischaemic heart disease. Br J Haematol 1994; 88:601-7.

9. Eren A, Friedl R, Hannekum A, Gulbins H. Cardiac surgery in a patient with haemophilia A. Thorac Cardiovasc Surg. 2006;54(3):212-4.

10. Grandmougin D, Delolme MC, Reynaud J, Barral X. Off-pump myocardial revascularization in a diabetic patient with severe haemophilia B and impaired left ventricular function: hematological and operative strategies. J Card Surg. 2005;20(4):366-9.

11. Leggett PL, Doyle D, Smith WB, Culpepper W 3rd, Cooper S, Ochsner JL. Elective cardiac operation in a patient with severe haemophilia and acquired factor VIII antibodies. J Thorac Cardiovasc Surg. 1984;87(4):556-60.

12. Palanzo DA, Sadr FS. Coronary artery bypass grafting in a patient with haemophilia B. Perfusion. 1995;10(4):265-70.

13. Ferrario C, Renders F, Cairoli A, Vuffray A, Spertini O, Angelillo-Scherrer A. Management of an acute coronary syndrome in a patient with severe haemophilia A. Haemophilia 2007; 13: 763–765.

14. Batorova A, Martinowitz U. Intermittent injections vs. continuous infusion of factor VIII in haemophilia patients undergoing major surgery.Br J Haematol. 2000;110(3):715-20.

Kaynak Göster